Qi Yi Luo
Director/Board Member bei MICROPORT SCIENTIFIC CORPORATION
Vermögen: 5 Mio $ am 31.03.2024
Profil
Derzeit ist Qi Yi Luo Non-Executive Chairman der MicroPort CardioFlow Medtech Corp. und Chief Technology Officer der MicroPort Scientific Corp. sowie Chairman der Shanghai MicroPort CardioFlow Medtech Co., Ltd. (eine Tochtergesellschaft von MicroPort Scientific Corp.). Herr Luo ist auch im Vorstand von Shanghai MicroPort EP MedTech Co., Ltd. Herr Luo erhielt einen Hochschulabschluss von der Queen's University, einen Bachelor-Abschluss von der Yunnan Technology & Business University und einen Doktortitel von der University of Shanghai Science & Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
30.08.2023 | 6 503 897 ( 0,35% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Qi Yi Luo
Unternehmen | Position | Beginn |
---|---|---|
MICROPORT SCIENTIFIC CORPORATION | Director/Board Member | 30.08.2023 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Director/Board Member | 28.04.2020 |
Ehemalige bekannte Positionen von Qi Yi Luo
Unternehmen | Position | Ende |
---|---|---|
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Director/Board Member | 15.09.2023 |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Chairman | 29.08.2023 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Chairman | 29.08.2023 |
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Director/Board Member | 01.01.1995 |
Ausbildung von Qi Yi Luo
Queen's University | Graduate Degree |
Yunnan Technology & Business University | Undergraduate Degree |
University of Shanghai for Science & Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Health Technology |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |